History
Viruses exact an enormous toll on the human population and are the single most important
cause of infectious disease morbidity and mortality worldwide. Viral diseases in humans
were first noted in ancient times and have since shaped our history. Scientific approaches
to the study of viruses and viral disease began in the 19th century and led to the
identification of specific disease entities caused by viruses. Careful clinical observations
enabled the identification of many viral illnesses and allowed several viral diseases
to be differentiated (e.g., smallpox vs. chickenpox and measles vs. rubella). Progress
in an understanding of disease at the level of cells and tissues, exemplified by the
pioneering work of Virchow, allowed the pathology of many viral diseases to be defined.
Finally, the work of Pasteur ushered in the systematic use of laboratory animals for
studies of the pathogenesis of infectious diseases, including those caused by viruses.
The first viruses were identified as the 19th century ended. Ivanovsky and Beijerinck
identified tobacco mosaic virus, and Loeffler and Frosch discovered foot-and-mouth
disease virus. These observations were quickly followed by the discovery of yellow
fever virus and the seminal research on the pathogenesis of yellow fever by Walter
Reed and the U. S. Army Yellow Fever Commission.
1
By the end of the 1930s, tumor viruses, bacteriophages, influenza virus, mumps virus,
and many arthropod-borne viruses had been identified. This process of discovery has
continued with growing momentum to the present, with recently identified skin cancer–associated
Merkel cell polyomavirus,
2
novel Old World arenaviruses causing fatal disease,3, 4 bat-related respiratory coronavirus
5
and reoviruses,6, 7 and novel swine- and avian-origin influenza viruses8, 9 counted
among the most recent entries in the catalog of human disease-causing viruses.
In the 1940s, Delbruck, Luria, and others10, 11 used bacteriophages as models to establish
many basic principles of microbial genetics and molecular biology and identified key
steps in viral replication. The pioneering experiments of Avery, MacLeod, and McCarty
12
on the transformation of pneumococci established DNA as the genetic material and set
the stage for corroborating experiments by Hershey and Chase using bacteriophages.
13
In the late 1940s, Enders and colleagues
14
cultivated poliovirus in tissue culture. This accomplishment led to the development
of both formalin-inactivated (Salk)
15
and live-attenuated (Sabin)
16
vaccines for polio and ushered in the modern era of experimental and clinical virology.
In recent years, x-ray crystallography has allowed visualization of virus structures
at an atomic level of resolution. Nucleotide sequences of entire genomes of most human
viruses are known, and functional domains of many viral structural and enzymatic proteins
have been defined. This information is being applied to the development of new strategies
to diagnose viral illnesses and design effective antiviral therapies. Techniques to
detect viral genomes, such as the polymerase chain reaction (PCR) and its derivatives,
have proven superior to conventional serologic assays and culture techniques for the
diagnosis of many viral diseases. Nucleic acid–based strategies are now used routinely
in the diagnosis of infections caused by enteroviruses, hepatitis B virus (HBV), hepatitis
C virus (HCV), herpesviruses, human immunodeficiency virus (HIV), and, with increasing
frequency, respiratory and enteric viral pathogens. Furthermore, rapid developments
in mass spectrometry and nucleotide sequencing technology are permitting the application
of these tools to highly sensitive and specific virus detection in clinical specimens.
Perhaps an even more exciting development is the means to introduce new genetic material
into viral genomes. Strategies now exist whereby specific mutations or even entire
genes can be inserted into the genomes of many viruses. Such approaches can be exploited
in the rational design of vaccines and the development of viral vectors for use in
gene delivery. Furthermore, these powerful new techniques are leading to breakthroughs
in foundational problems in viral pathogenesis, such as the nature of virus–cell interactions
that produce disease, immunoprotective and immunopathologic host responses to infection,
and viral and host determinants of contagion. Improved understanding of these aspects
of viral infection will facilitate new approaches to the prevention, diagnosis, and
treatment of viral diseases.
Virus Structure and Classification
The first classification of viruses as a group distinct from other microorganisms
was based on the capacity to pass through filters of a small pore size (filterable
agents). Initial subclassifications were based primarily on pathologic properties
such as specific organ tropism (e.g., hepatitis viruses) or common epidemiologic features
such as transmission by arthropod vectors (e.g., arboviruses). Current classification
systems are based on the following: (1) the type and structure of the viral nucleic
acid and the strategy used in its replication; (2) the type of symmetry of the virus
capsid (helical vs. icosahedral); and (3) the presence or absence of a lipid envelope
(Table 134-1
).
TABLE 134-1
Classification of Viruses
FAMILY
EXAMPLE
TYPE OF NUCLEIC ACID
GENOME SIZE (kb or kb pair)
ENVELOPE
CAPSID SYMMETRY
RNA-Containing Viruses
Picornaviridae
Poliovirus
SS (+) RNA
7-9
No
I
Astroviridae
Astrovirus
SS (+) RNA
6-7
No
I
Caliciviridae
Norwalk virus
SS (+) RNA
7-8
No
I
Togaviridae
Rubella virus
SS (+) RNA
10-12
Yes
I
Flaviviridae
Yellow fever virus
SS (+) RNA
10-12
Yes
S
Coronaviridae
Coronavirus
SS (+) RNA
28-31
Yes
H
Rhabdoviridae
Rabies virus
SS (−) RNA
11-15
Yes
H
Paramyxoviridae
Measles virus
SS (−) RNA
13-18
Yes
H
Filoviridae
Ebola virus
SS (−) RNA
19
Yes
H
Arenaviridae
Lymphocytic choriomeningitis virus
2 SS (ambisense) RNA segments
11
Yes
S
Bunyaviridae
California encephalitis virus
3 SS (ambisense) RNA segments
11-19
Yes
H
Orthomyxoviridae
Influenza virus
6-8 SS (−) RNA segments*
10-15
Yes
H
Reoviridae
Rotavirus
10-12 DS RNA segments*
19-32
No
I
Retroviridae
HIV
2 identical SS (+) RNA segments
7-13
Yes
S
DNA-Containing Viruses
Hepadnaviridae
Hepatitis B virus
Circular DS DNA with SS portions
3-4
Yes
I
Parvoviridae
Human parvovirus B19
SS (+) or (−) DNA
4-6
No
I
Polyomaviridae
JC virus
Circular DS DNA
5
No
I
Papillomaviridae
Human papillomavirus
Circular DS DNA
7-8
No
I
Adenoviridae
Adenovirus
Linear DS DNA
26-45
No
I
Herpesviridae
Herpes simplex virus
Linear DS DNA
125-240
Yes
I
Poxviridae
Vaccinia virus
Linear DS DNA
130-375
Yes
Complex
(+), message sense; (−), complement of message sense; DS, double-stranded; H, helical;
I, icosahedral; S, spherical; SS, single-stranded.
*
Reovirus and orbivirus, 10 segments; rotavirus, 11 segments; Colorado tick fever virus,
12 segments.
Data from Condit RC. Principles of virology. In: Knipe DM, Howley PM, eds. Fields
Virology. 5th ed. Philadelphia: Lippincott-Raven Press; 2007:25-57.
Virus particles—virions—can be functionally conceived as a delivery system that surrounds
a payload. The delivery system consists of structural components used by the virus
to survive in the environment and bind to host cells. The payload contains the viral
genome and often includes enzymes required for the initial steps in viral replication.
In almost all cases, the delivery system must be removed from the virion to allow
viral replication to commence.
In addition to mediating attachment to host cells, the delivery system also plays
a crucial role in determining the mode of transmission between hosts. Viruses containing
lipid envelopes are sensitive to desiccation in the environment and, for the most
part, are transmitted by the respiratory, parenteral, and sexual routes. Nonenveloped
viruses are stable to harsh environmental conditions and are often transmitted by
the fecal-oral route.
Viral genomes exist in a variety of forms and sizes and consist of RNA or DNA (see
Table 134-1). Animal virus genomes range in size from 3 kb, encoding only three or
four proteins in small viruses such as the hepadnaviruses, to more than 300 kb, encoding
several hundred proteins in large viruses such as the poxviruses. Viral genomes are
single- or double-stranded and circular or linear. RNA genomes are composed of a single
molecule of nucleic acid or multiple discrete segments, which can vary in number from
as few as two in the arenaviruses up to 12 in some members of the Reoviridae. Viral
nucleic acid is packaged in a protein coat, or capsid, that consists of multiple protein
subunits. The combination of the viral nucleic acid and the surrounding protein capsid
is often referred to as the nucleocapsid (Fig. 134-1
).
FIGURE 134-1
Schematic diagrams illustrating the structure of a nonenveloped icosahedral virus
(A) and an enveloped helical virus (B). Nucleocapsid: combination of a viral nucleic
acid and surrounding protein capsid.
Structural details of many viruses have now been defined at an atomic level of resolution
(Fig. 134-2
). General features of virus structure can be gained from examination of electron
micrographs of negatively stained virions and thin-section electron micrographs of
virus-infected tissues and cultured cells. These techniques allow rapid identification
of viral size, shape, symmetry, and surface features, presence or absence of an envelope,
and intracellular site of viral assembly. Cryoelectron microscopy and computer image
processing techniques are used to determine the three-dimensional structures of spherical
viruses at a level of resolution far superior to that of negatively stained electron
micrographs. A major advantage of cryoelectron microscopy is that it allows structural
studies of viruses to be performed under conditions that do not alter native virion
structure. Moreover, recent advances in cryoelectron microscopy have extended the
achievable resolution of particle-associated proteins to near-atomic levels, sufficient
to recognize characteristic features of secondary structural elements.
17
Image reconstructions of cryoelectron micrographs, sometimes in combination with x-ray
crystallography, can also be used to investigate structural aspects of various virus
functions, including receptor binding18, 19, 20 and interaction with antibodies.21,
22 Identification of key motifs, such as receptor binding sites or immunodominant
domains, provides the framework for understanding the structural basis of virus–cell
interactions. Electron tomography with image reconstruction has been applied to architectural
studies of viruses and intracellular foci of virus replication, rendering exquisite
three-dimensional representations of particle organization and revealing the structure
and subcellular origins of virus manufacturing centers.23, 24
FIGURE 134-2
Structural studies of poliovirus.
A, Negative-stained electron micrograph. B, Three-dimensional image reconstruction
of cryoelectron micrographs. C, Structure determined by x-ray crystallography.
(Courtesy Dr. James Hogle, Harvard University.)
A number of general principles have emerged from studies of virus structure. In almost
all cases, the capsid is composed of a repeating series of structurally similar subunits,
each of which in turn is composed of only a few different proteins. The parsimonious
use of structural proteins in a repetitive motif minimizes the amount of genetic information
required to encode the viral capsid and leads to structural arrangements with symmetrical
features. All but the most complex viruses exhibit either helical or icosahedral symmetry
(see Table 134-1). Viruses with helical symmetry contain repeating protein subunits
bound at regular intervals along a spiral formed by the viral nucleic acid. Interestingly,
all known animal viruses that show this type of symmetry have RNA genomes. Viruses
with icosahedral symmetry display twofold, threefold, and fivefold axes of rotational
symmetry, and viral nucleic acid is intimately associated with specific capsid proteins
in an ordered packing arrangement.
The use of repeating subunits with symmetrical protein-protein interactions facilitates
the assembly of the viral capsid. In most cases, viral assembly appears to be a spontaneous
process that occurs under the appropriate physiologic conditions and often can be
reproduced when recombinant viral proteins are expressed in the absence of viral replication.25,
26 For many viruses, assembly of the capsid proceeds through a series of intermediates,
each of which nucleates the addition of subsequent components in the assembly sequence.
One of the most poorly understood aspects of viral assembly is the process that ensures
that the viral nucleic acid is correctly packaged into the capsid. In the case of
viruses with helical symmetry, there may be an initiation site on the nucleic acid
to which the initial capsid protein subunit binds, triggering the addition of subsequent
subunits. The genomes of most DNA-containing viruses are inserted into preassembled
capsid intermediates (procapsids) through adenosine triphosphate–driven mechanisms.
27
In preparations of many icosahedral viruses, empty capsids (i.e., capsids lacking
nucleic acid) are frequently observed, indicating that assembly may proceed to completion
without a requirement for the viral genome.
In some viruses, the nucleocapsid is surrounded by a lipid envelope acquired as the
virus particle buds from the host cell cytoplasmic, nuclear, or endoplasmic reticular
membrane (see Fig. 134-1). Inserted into this lipid bilayer are virus-encoded proteins
(e.g., the hemagglutinin [HA] and neuraminidase proteins of influenza virus and gp41
and gp120 of HIV), which are exposed on the surface of the virus particle. These viral
proteins usually contain a glycosylated hydrophilic external portion and internal
hydrophobic domains that span the lipid membrane and anchor the protein into the viral
envelope. In some cases, another viral protein, often termed a matrix protein, associates
with the internal (cytoplasmic) surface of the lipid envelope, where it can interact
with the cytoplasmic domains of the envelope glycoproteins. Matrix proteins may play
roles in stabilizing the interaction between viral glycoproteins and the lipid envelope,
directing the viral genome to intracellular sites of viral assembly, or facilitating
viral budding. Matrix proteins can also influence a diverse set of cellular functions,
such as inhibition of host cell transcription28, 29 and evasion of the cellular innate
antiviral response.
30
Virus–Cell Interactions
Viruses require an intact cell to replicate and can direct the synthesis of hundreds
to thousands of progeny viruses during a single cycle of infection. In contrast to
other microorganisms, viruses do not replicate by binary fission. Instead, the infecting
particle must disassemble in order to direct synthesis of viral progeny.
Attachment
The interaction between a virus and its host cell begins with attachment of the virus
particle to specific receptors on the cell surface. Viral proteins that mediate the
attachment function (viral attachment proteins) include the following: single-capsid
components that extend from the virion surface, such as the attachment proteins of
adenovirus,
31
reovirus,
32
and rotavirus33, 34; surface glycoproteins of enveloped viruses, such as influenza
virus35, 36 (Fig. 134-3
) and HIV37, 38; viral capsid proteins that form binding pockets that engage cellular
receptors, such as the canyon formed by the capsid proteins of poliovirus
39
and rhinovirus
40
; and viral capsid proteins that contain extended loops capable of binding receptors,
such as foot-and-mouth disease virus.
41
Studies of the attachment of several diverse virus groups, including adenoviruses,
coronaviruses, herpesviruses, lentiviruses, and reoviruses, indicate that multiple
interactions between virus and cell occur during the attachment step. These observations
indicate that a specific sequence of binding events between virus and cell optimizes
specificity and contributes significant stability to the association.
42
FIGURE 134-3
The folded structure of the influenza virus hemagglutinin (HA) and its rearrangement
when exposed to low pH.
A, The HA monomer. HA1 is blue, and HA2 is multicolored. The receptor-binding pocket
resides in the virion-distal portion of HA1. The viral membrane would be at the bottom
of this figure. B, Conformational change in HA induced by exposure to low pH. Note
the dramatic structural rearrangement in HA2, in which amino acid residues 40-105
become a continuous alpha helix. Dashed lines indicate regions of undetermined structure.
This model of HA in its fusion conformation is a composite of the HA1 domain structure
and the low-pH HA2 structure.
(Modified from Russell RJ, Kerry PS, Stevens DJ, et al. Structure of influenza hemagglutinin
in complex with an inhibitor of membrane fusion. Proc Natl Acad Sci U S A. 2008;105:17736-17741.)
One of the most dynamic areas of virology concerns the identification of virus receptors
on host cells. This interest stems in part from the critical importance of the attachment
step as a determinant of target cell selection by many viruses. Several virus receptors
have now been identified (Table 134-2
), and three important principles have emerged from studies of these receptors. First,
viruses have adapted to use cell surface molecules designed to facilitate a variety
of normal cellular functions. Virus receptors may be highly specialized proteins with
limited tissue distribution, such as complement receptors, growth factor receptors,
or neurotransmitter receptors, or more ubiquitous components of cellular membranes,
such as integrins and other intercellular adhesion molecules, glycosaminoglycans,
or sialic acid–containing oligosaccharides. Second, many viruses use more than a single
receptor to mediate multistep attachment and internalization. For example, adenovirus
binds coxsackievirus and adenovirus receptor (CAR)
43
and the integrins αvβ3 or αvβ5
44
; herpes simplex virus (HSV) binds heparan sulfate45, 46, 47 and herpesvirus entry
mediator (HVEM/HveA),
48
nectin 1 (PRR1/HveC),
49
or nectin 2 (PRR2/HveB)
50
; HIV binds CD451, 52 and chemokine receptors CXCR453, 54 or CCR555, 56, 57; and reovirus
binds sialylated glycans58, 59 and JAM-A.60, 61 Third, in many cases, receptor expression
is not the sole determinant of viral tropism for particular cells and tissues in the
host. Therefore, although receptor binding is the first step in the interaction between
virus and cell, subsequent events in the viral replication cycle must also be supported
for productive viral infection to occur.
TABLE 134-2
Receptors and Entry Mediators Used by Selected Human Viruses
VIRUS
RECEPTOR
Adenovirus
Coxsackievirus and adenovirus receptor (CAR)43, 263
CD46264, 265
Integrins αvβ3, αvβ5
44
Sialic acid–containing oligosaccharides
266
Coronavirus
9-O-acetylated sialic acid–containing oligosaccharides (HCoV-OC43)
267
Aminopeptidase N (HCoV-229E)268, 269
Angiotensin-converting enzyme 2 (SARS-CoV
270
and NL63
271
)
Dipeptidyl peptidase 4 (MERS-CoV)
272
Coxsackievirus
Integrin αvβ3
273
Decay-accelerating factor (CD55)274, 275
Coxsackievirus and adenovirus receptor (CAR)
43
Intercellular adhesion molecule 1 (ICAM-1)
276
GRP78/BiP
277
Heparan sulfate
278
Cytomegalovirus
Heparan sulfate279, 280
Integrins α2β1, α6β1, αvβ3
281
Platelet-derived growth factor-α receptor
282
Echovirus
Integrin α2β1
283
Decay accelerating factor (CD55)284, 285
Ebola virus
Niemann-Pick C1 cholesterol transporter286, 287
Enterovirus 71
P-selectin glycoprotein ligand-1 (PSGL-1)
288
Scavenger receptor B2 (SR-B2)
289
Epstein-Barr virus
Complement receptor 2 (CD21)290, 291
MHC class II protein
77
Hantaviruses
β3 Integrins
292
Henipaviruses
Ephrin-B2293, 294
Hepatitis A virus
Mucin-like protein TIM-1
295
Hepatitis C virus
CD81296, 297
Scavenger receptor B1 (SRB1)298, 299
Claudin
300
Occludin
301
Herpes simplex virus
Heparan sulfate45, 46, 47
Herpesvirus entry mediator (HVEM/HveA)
48
Nectin 1 (PRR1/HveC)
49
Nectin 2 (PRR2/HveB)
50
Human immunodeficiency virus
CD451, 52
Chemokine receptor CXCR453, 54
Chemokine receptor CCR555, 56, 57
Human metapneumovirus
Integrin αvβ1
302
Human T-cell leukemia virus
Glucose transporter GLUT-1
303
Neuropilin-1
304
Influenza virus
Sialic acid–containing oligosaccharides36, 305
JC polyomavirus
Serotonin receptor 5HT2A
317
LSTc pentasaccharide
74
Kaposi sarcoma herpesvirus
Integrin α3β1
306
Measles virus
CD46307, 308
Signaling lymphocyte-activation molecule (SLAM)
309
Nectin-4310, 311
New World hemorrhagic fever arenaviruses (e.g., Junin virus)
Transferrin receptor 1
312
Norovirus
Histo-blood group antigens313, 314
Old World hemorrhagic fever arenaviruses (e.g., Lassa fever virus)
α-Dystroglycan
315
Parvovirus B19
Erythrocyte P antigen (globoside)
316
Poliovirus
Poliovirus receptor (PVR, CD155)
183
Rabies virus
Neural cell adhesion molecule (CD56)
318
Nerve growth factor receptor (P75NTR)
319
Reovirus
Sialic acid–containing oligosaccharides58, 59
Junctional adhesion molecule-A (JAM-A)
60
β1 integrins
320
Rhinovirus (major group)
Intercellular adhesion molecule 1 (ICAM-1)321, 322, 323
Rhinovirus (minor group)
Low-density lipoprotein receptor
324
Rotavirus
Sialic acid–containing oligosaccharides325, 326
Integrins α2β1, α4β1, αvβ3, αxβ2
327, 328
Rubella virus
Myelin oligodendrocyte glycoprotein (MOG)
329
Sindbis virus
Natural resistance–associated macrophage protein (NRAMP)
330
Several viruses bind receptors expressed at regions of cell-cell contact.
62
Junctional adhesion molecule-A (JAM-A), which serves as a receptor for reovirus
60
and feline calicivirus,
63
and CAR, which serves as a receptor for some coxsackieviruses and adenoviruses,
43
are expressed at tight junctions64, 65 and adherens junctions.66, 67 Junctional regions
are sites of enhanced membrane recycling, endocytic uptake, and intracellular signaling.
68
Therefore, it is possible that viruses have selected junction-associated proteins
as receptors to usurp the physiologic functions of these molecules. In this regard,
interactions of coxsackievirus with decay-accelerating factor elicit a tyrosine kinase–based
signaling cascade that mediates subsequent interactions of the virus with CAR in tight
junctions.
69
Structures of viral proteins or whole viral particles in complex with sialic acid
have been determined for some viruses, including the influenza virus hemagglutinin
(HA)36, 70 (see Fig. 134-3), polyomavirus,71, 72, 73, 74 foot-and-mouth disease virus,
75
reovirus attachment protein σ1,58, 59 and the VP8 domain of rotavirus capsid protein
VP4.
34
Sialic acid binding in each of these cases occurs in a shallow groove at the surface
of the viral protein. However, the architectures of the binding sites differ. Structures
of complexes of viral proteins or viral particles and cell surface protein receptors
have also been determined. These include adenovirus fiber knob and CAR,
76
Epstein-Barr virus (EBV) gp42 and major histocompatibility complex (MHC) class II
protein,
77
HSV glycoprotein D and HVEM/HveA,
78
HIV gp120 and CD4,
38
measles virus HA and CD46
79
and SLAM (signaling lymphocyte-activation molecule),
80
reovirus σ1 and JAM-A,
61
and rhinovirus and ICAM-1 (intercellular adhesion molecule 1).
81
In several of these cases, the viral attachment proteins engage precisely the same
domains used by their cognate receptors to bind natural ligands.
Penetration and Disassembly
Once attachment has occurred, the virus must penetrate the cell membrane, and the
capsid must undergo a series of disassembly steps (uncoating) that prepare the virus
for the next phases in viral replication. Enveloped viruses such as the paramyxoviruses
and retroviruses enter cells by fusion of the viral envelope with the cell membrane
(Fig. 134-4
). Attachment of these viruses to the cell surface induces changes in viral envelope
proteins required for membrane fusion. For example, the binding of CD4 and certain
chemokine receptors by HIV envelope glycoprotein gp120 induces a series of conformational
changes in gp120 that lead to the exposure of transmembrane protein gp41.82, 83 Fusion
of viral and cellular membranes proceeds through subsequent interactions of the hydrophobic
gp41 fusion peptide with the cell membrane.84, 85, 86, 87
FIGURE 134-4
Mechanisms of viral entry into cells.
Nonenveloped (A) and enveloped (B) virus internalization by receptor-mediated endocytosis.
Other viruses enter cells by some form of receptor-mediated endocytic uptake (see
Fig. 134-4). For several viruses, virus–receptor complexes induce formation of clathrin-coated
pits that invaginate from the cell membrane to form coated vesicles.
88
These vesicles are rapidly uncoated and fuse with early endosomes, which sort internalized
proteins for recycling to the cell surface or other cellular compartments, such as
late endosomes or lysosomes. For other viruses, virus–receptor complexes are taken
into cells by caveolae in lipid rafts.
88
Enveloped viruses such as dengue virus,
89
influenza virus,
90
and Semliki Forest virus
91
exploit the acidic environment of the endocytic compartment to induce conformational
changes in surface glycoproteins required for membrane fusion. High-resolution structures
of the influenza virus HA at acidic pH illustrate a dramatic conformational alteration
leading to the fusion-active state (see Fig. 134-3).
90
Endocytic uptake and acidification are also required for entry of some nonenveloped
viruses such as adenovirus,92, 93 parvovirus,
94
and reovirus.95, 96 In these cases, acidic pH may facilitate disassembly of the viral
capsid to enable subsequent penetration of endosomal membranes. In addition to acidic
pH, endocytic cathepsin proteases are required for disassembly of several viruses,
including Ebola virus,
97
Hendra virus,
98
reovirus,
99
and severe acute respiratory syndrome (SARS) coronavirus.
100
In contrast to enveloped viruses, nonenveloped viruses cross cell membranes using
mechanisms that do not involve membrane fusion. This group of viruses includes several
human pathogens, with adenoviruses, picornaviruses, and rotaviruses serving as prominent
examples. Despite differences in genome and capsid composition, each of these viruses
must penetrate cell membranes to deliver the genetic payload to the interior of the
cell. Capsid rearrangements triggered by receptor binding,101, 102 acidic pH,92, 93
or proteolysis103, 104 serve essential functions in membrane penetration by some nonenveloped
viruses. Although a precise understanding of the biochemical mechanisms that underlie
viral membrane penetration is incomplete, small capsid proteins of several nonenveloped
viruses, such as adenovirus,
105
poliovirus,
106
and reovirus,
107
are required for membrane penetration, perhaps by forming pores in host cell membranes.
Genome Replication
Once a virus has entered a target cell, it must replicate its genome and proteins.
Replication strategies used by single-stranded RNA-containing viruses depend on whether
the genome can be used as messenger (m)RNA. Translation-competent genomes, which include
those of the coronaviruses, flaviviruses, picornaviruses, and togaviruses, are termed
plus (+) sense and are translated by cellular ribosomes immediately following entry
of the genome into the cytoplasm. For most viruses containing (+) sense RNA genomes,
translation results in the synthesis of a large polyprotein that is cleaved into several
smaller proteins through the action of viral and sometimes host proteases. One of
these proteins is an RNA-dependent RNA polymerase (RdRp), which replicates the viral
RNA. Genome replication of (+) sense RNA-containing viruses requires synthesis of
a minus (–) sense RNA intermediate, which serves as template for production of (+)
sense genomic RNA.
A different strategy is used by viruses containing (−) sense RNA genomes. The genomes
of these viruses, which include the filoviruses, orthomyxoviruses, paramyxoviruses,
and rhabdoviruses, cannot serve directly as mRNA. Therefore, viral particles must
contain a co-packaged RdRp to transcribe (+) sense mRNAs using the (−) sense genomic
RNA as template. Genome replication of (−) sense RNA-containing viruses requires synthesis
of a (+) sense RNA intermediate, which serves as a template for production of (−)
sense genomic RNA. Mechanisms that determine whether (+) sense RNAs are used as templates
for translation or genome replication are not well understood.
RNA-containing viruses belonging to the family Reoviridae have segmented double-stranded
(ds) RNA genomes. The innermost protein shell of these viruses (termed a single-shelled
particle or core) contains an RdRp that catalyzes the synthesis of (+) sense mRNA
using as a template the (−) sense strand of each dsRNA segment. The mRNAs of these
viruses are capped at their 5′-termini by virus-encoded enzymes and then extruded
into the cytoplasm through channels in the single-shelled particle.
108
The (+) sense mRNAs also serve as a template for replication of dsRNA gene segments.
Viral genome replication is thus completely conservative; neither strand of parental
dsRNA is present in newly formed genomic segments.
The retroviruses are RNA-containing viruses that replicate using a DNA intermediate.
The viral genomic RNA is (+) sense and single stranded; however, it does not serve
as mRNA following viral entry. Instead, the retrovirus RNA genome is a template for
synthesis of a double-stranded DNA copy, termed the provirus. Synthesis of the provirus
is mediated by a virus-encoded RNA-dependent DNA polymerase or reverse transcriptase,
so named because of the reversal of genetic information from RNA to DNA. The provirus
translocates to the nucleus and integrates into host DNA. Expression of this integrated
DNA is regulated for the most part by cellular transcriptional machinery. However,
the human retroviruses HIV and human T-cell leukemia virus (HTLV) encode proteins
that augment transcription of viral genes. Intracellular signaling pathways are capable
of activating retroviral gene expression and play important roles in inducing high
levels of viral replication in response to certain stimuli.
109
Transcription of the provirus yields mRNAs that encode viral proteins and genome-length
RNAs that are packaged into progeny virions. Such a replication strategy results in
persistent infection in the host because the viral genome is maintained in the host
cell genome and replicated with each cell division.
With the exception of the poxviruses, viruses containing DNA genomes replicate in
the nucleus and for the most part use cellular enzymes for transcription and replication
of their genomes. Transcription of most DNA-containing viruses is tightly regulated
and results in the synthesis of early and late mRNA transcripts. The early transcripts
encode regulatory proteins and proteins required for DNA replication, whereas the
late transcripts encode structural proteins. Several DNA-containing viruses, such
as adenovirus and human papillomavirus (HPV), induce cells to express host proteins
required for viral DNA replication by stimulating cell-cycle progression. For example,
the HPV E7 protein binds the retinoblastoma gene product pRB and liberates transcription
factor E2F, which induces the cell cycle.110, 111 To prevent programmed cell death
in response to E7-mediated unscheduled cell cycle progression, the HPV E6 protein
mediates the ubiquitylation and degradation of tumor suppressor protein p53.112, 113,
114
Some DNA-containing viruses, such as the herpesviruses, can establish latent infections
in the host. Unlike the retroviruses, genomes of the herpesviruses do not integrate
into host chromosomes but instead exist as plasmid-like episomes. Mechanisms that
govern establishment of latency and subsequent reactivation of replication are not
well understood. However, microRNAs encoded by cytomegalovirus (CMV) and perhaps
other herpesviruses may promote persistence by targeting viral and cellular mRNAs
that control viral gene expression and replication and innate immune responses to
viral infection.115, 116
A fascinating aspect of virus–cell interactions is the replication microenvironments
established in infected cells. Viral replication is a sophisticated interplay of transcription,
translation, nucleic acid amplification, and particle assembly. Furthermore, infection
must proceed under sensitive pathogen surveillance systems trained on virus-associated
molecular patterns (e.g., unmethylated CpG dinucleotides in DNA viral genomes) and
replicative intermediates (e.g., dsRNA generated during RNA virus replication) that
may impose impassable blocks to infection.
117
Partitioning of the viral replication machinery from the surrounding intracellular
milieu satisfies a spatial requirement to concentrate viral proteins and nucleic acid
for efficient genome amplification and encapsidation while simultaneously shielding
viral products from cellular sensors that provoke antiviral innate immune responses.
Hence, as a rule, viral replication is a localized process, occurring within morphologically
discrete cytoplasmic or nuclear structures variously termed viral inclusions (or inclusion
bodies), virosomes, viral factories, or viroplasm. These entities are novel, metabolically
active organelles formed by contributions from both virus and cell. Many highly recognizable
features of viral cytopathic effect observed using light microscopy, such as dense
nuclear inclusions or refractile cytoplasmic densities, represent locally concentrated
regions of viral nucleic acid and protein.
Membrane-associated replicase complexes appropriated by (+) sense RNA viruses are
perhaps the most conspicuous examples of compartmentalized viral replication. In cells
infected by these viruses, intracellular membranes originating from the endoplasmic
reticulum (ER; e.g., picornaviruses118, 119), ER-Golgi intermediate compartment and
trans-Golgi network (e.g., flaviviruses
120
), endolysosomal vesicles (e.g., alphaviruses
121
), and autophagic vacuoles (e.g., poliovirus
122
) are reduplicated and reorganized by viral proteins into platforms that anchor viral
replication complexes consisting of the RdRp and other RNA-modifying enzymes necessary
for RNA synthesis. Curiously, dsRNA viruses are thought to generate nonmembranous
intracytoplasmic replication factories, even though their life cycles pass through
a (+) polarity RNA intermediate. However, in an interesting functional parallel with
(+) sense RNA viruses, the assembly pathway of rotavirus, a dsRNA virus, involves
budding of immature particles into the ER, where a lipid envelope is transiently acquired
and subsequently replaced by the outermost protein shell.
123
Perhaps additional roles for cellular membranes in non–membrane-bound viral replication
complexes await discovery.
The tight relationship of RNA virus replication to cellular membranes is less predictable
for DNA viruses. For example, in distinction to the supporting role of autophagy in
the replication of some RNA viruses, autophagosomes (stress-induced, double-membraned
vesicles that remove noxious cytoplasmic materials to lysosomes for degradation) defend
against infection by HSV-1, which encodes a protein that inhibits induction of autophagy
and accentuates viral virulence.124, 125 The replication and assembly complexes of
many DNA viruses, including adenoviruses, herpesviruses, papillomaviruses, polyomaviruses,
and parvoviruses, are associated with promyelocytic leukemia (PML) nuclear bodies,126,
127 which have been ascribed functions in diverse nuclear processes encompassing gene
regulation, tumor suppression, apoptosis, and removal of aggregated or foreign proteins.
128
It appears that DNA viruses exploit PML bodies in a variety of ways, which include
consolidation and disposal of misfolded viral proteins, sequestration of host-cell
stress response factors that block infection, and segregation of interfering cellular
DNA repair proteins from sites of viral replication.
129
The life cycles of all viruses that replicate in eukaryotic cells are physically and
functionally intertwined with the cytoskeleton. Many viruses with nuclear replication
programs, such as adenovirus, HSV, and influenza virus, are transported by motor proteins
along microtubules toward the nucleus, resulting ultimately in release of the viral
genome into the nucleoplasm through nuclear pores.
130
The microtubule network is also conscripted as an egress pathway by a number of enveloped
viruses (e.g., HIV, HSV, vaccinia virus) for conveyance of immature particles to cytolemmal
sites of virion budding.
131
Furthermore, microtubules and actin filaments may serve as anchorage points for nucleoprotein
complexes that coordinate genome expression or replication with cytoplasmic replication
programs, exemplified by parainfluenza virus (PIV),
132
reovirus,
133
and vaccinia virus.
134
Because the cytoskeleton is a decentralized organelle linking cellular structural
elements to the metabolic and transport machineries, it is not surprising that viruses
capitalize on this highly integrative system, which provides a stable platform for
replication and enables purposeful movement of virions or subviral components within
cells to facilitate the requisite partitioning of viral assembly and disassembly.
Cell Killing
Viral infection can compromise numerous cellular processes, such as nucleic acid and
protein synthesis, maintenance of cytoskeletal architecture, and preservation of membrane
integrity.
135
Many viruses are also capable of inducing the genetically programmed mechanism of
cell death that leads to apoptosis of host cells.136, 137 Apoptotic cell death is
characterized by cell shrinkage, membrane blebbing, condensation of nuclear chromatin,
and activation of an endogenous endonuclease, which results in cleavage of cellular
DNA into oligonucleosome-length DNA fragments.
138
These changes occur according to predetermined developmental programs or in response
to certain environmental stimuli. In some cases, apoptosis may serve as an antiviral
defense mechanism to limit viral replication by destruction of virus-infected cells
or reduction of potentially harmful inflammatory responses elicited by viral infection.
139
In other cases, apoptosis may result from viral induction of cellular factors required
for efficient viral replication.136, 137 Generally, RNA-containing viruses, including
influenza virus, measles virus, poliovirus, reovirus, and Sindbis virus, induce apoptosis
of host cells, whereas DNA-containing viruses, including adenovirus, CMV, EBV, HPV,
and the poxviruses, encode proteins that block apoptosis. For some viruses, the duration
of the viral infectious cycle may determine whether apoptosis is induced or inhibited.
Viruses capable of completing an infectious cycle before induction of apoptosis would
not require a means to inhibit this cellular response to viral infection. Interestingly,
several viruses that cause encephalitis are capable of inducing apoptosis of infected
neurons (Fig. 134-5
).140, 141, 142
FIGURE 134-5
Reovirus-induced apoptosis in the murine central nervous system.
Consecutive sections of the hippocampus prepared from a newborn mouse 10 days following
intracranial inoculation with reovirus strain type 3 Dearing. Cells were stained with
(A) hematoxylin and eosin, (B) reovirus antigen, and (C) the activated form of apoptosis
protease caspase-3. Cells that stain positive for reovirus antigen or activated caspase
3 contain a dark precipitate in the cytoplasm, including neuronal processes. Scale
bars, 100 µm.
(Modified from Danthi P, Coffey CM, Parker JS, et al. Independent regulation of reovirus
membrane penetration and apoptosis by the µ1 Φ domain. PLoS Pathog. 2008;4:e1000248.)
Antiviral Drugs
(Also see Chapters 43 to 47Chapter 43Chapter 44Chapter 45Chapter 46Chapter 47.)
Knowledge of viral replication strategies has provided insights into critical steps
in the viral life cycle that can serve as potential targets for antiviral therapy.
For example, drugs can be designed to interfere with virus binding to target cells
or prevent penetration and disassembly once receptor engagement has occurred. Steps
involved in the replication of the viral genome are also obvious targets for antiviral
therapy. A number of antiviral agents inhibit viral polymerases, including those active
against herpesviruses (e.g., acyclovir), HIV (e.g., zidovudine), and HBV (e.g., entecavir).
Drugs that inhibit viral proteases have been developed; several are used to treat
HCV143, 144 and HIV
145
infection. These drugs block the proteolytic processing of viral precursor polyproteins
and serve as potent inhibitors of replication. Other viral enzymes also serve as targets
for antiviral therapy. The influenza virus neuraminidase is required for the release
of progeny influenza virus particles from infected cells. Oseltamivir and zanamivir
bind the neuraminidase catalytic site and efficiently inhibit the enzyme.
146
These drugs have been used in the prophylaxis and treatment of influenza virus infection.
147
Better understanding of viral replication strategies and mechanisms of virus-induced
cell killing is paving the way for the rational design of novel antiviral therapeutics.
One of the most exciting approaches to the development of antiviral agents is the
use of high-resolution x-ray crystallography and molecular modeling to optimize interactions
between these inhibitory molecules and their target viral proteins. Such structure-based
drug design has led to the development of synthetic peptides (e.g., enfuvirtide) that
inhibit HIV entry by blocking gp41-mediated membrane fusion.
148
Other vulnerable steps in HIV replication are targets of drugs approved for patient
treatment, including entry inhibitors that interfere with gp120 binding to CCR5
149
and agents that prevent proviral integration into cellular DNA through inhibition
of viral integrase activity
150
(see Chapter 130). Several inhibitors of the HCV protease and polymerase are also
in clinical development
151
(see Chapter 46).
Despite promising advances in rational antiviral drug design, current therapeutic
approaches to some viral infections rely heavily on compounds with less specific mechanisms
of action. One such agent, interferon (IFN)-α, efficiently inhibits a broad spectrum
of viruses and is secreted by diverse cell types as part of the host innate immune
response. Recombinant IFN-α is presently used to treat HBV and HCV infections. Ribavirin,
a synthetic guanosine analogue, inhibits the replication of many RNA- and DNA-containing
viruses through complex mechanisms involving inhibition of viral RNA synthesis and
disturbances in intracellular pools of guanosine triphosphate.152, 153 This drug is
routinely used to treat HCV infection and sometimes administered in aerosolized form
to treat respiratory syncytial virus (RSV) lower respiratory tract infection in hospitalized
children and in severely ill and immunocompromised patients. Ribavirin therapy reduces
the mortality associated with certain viral hemorrhagic fevers, such as that caused
by Lassa virus.
154
Broader-spectrum therapies exemplified by IFN-α and ribavirin remain part of the first-line
defense against emerging pathogens and other susceptible viruses for which biochemical
and structural information is insufficient to design high-potency agent-specific drugs.
Virus–Host Interaction
One of the most formidable challenges in virology is to apply knowledge gained from
studies of virus–cell interactions in tissue culture systems to an understanding of
how viruses interact with host organisms to cause disease. Virus–host interactions
are often described in terms of pathogenesis and virulence. Pathogenesis is the process
whereby a virus interacts with its host in a discrete series of stages to produce
disease (Table 134-3
). Virulence is the capacity of a virus to produce disease in a susceptible host.
Virulence is often measured in terms of the quantity of virus required to cause illness
or death in a predefined fraction of experimental animals infected with the virus.
Virulence is dependent on viral and host factors and must be measured using carefully
defined conditions (e.g., virus strain, dose, and route of inoculation; host species,
age, and immune status). In many cases, it has been possible to identify roles played
by individual viral and host proteins at specific stages in viral pathogenesis and
to define the importance of these proteins in viral virulence.
TABLE 134-3
Stages in Virus–Host Interaction
1.
Entry into the host
2.
Primary replication
3.
Spread
4.
Cell and tissue tropism
5.
Secondary replication
6.
Cell injury or persistence
7.
Host immune response
Entry
The first step in the process of virus–host interaction is the exposure of a susceptible
host to viable virus under conditions that promote infection (Fig. 134-6
). Infectious virus may be present in respiratory droplets or aerosols, in fecally
contaminated food or water, or in a body fluid or tissue (e.g., blood, saliva, urine,
semen, or a transplanted organ) to which the susceptible host is exposed. In some
cases, the virus is inoculated directly into the host through the bite of an animal
vector or through the use of a contaminated needle. Infection can also be transmitted
from mother to infant through virus that has infected the placenta or birth canal
or by virus in breast milk. In some cases, acute viral infections result from the
reactivation of endogenous latent virus (e.g., reactivation of HSV giving rise to
herpes labialis) rather than de novo exposure to exogenous virus.
FIGURE 134-6
Entry and spread of viruses in human hosts.
Some major steps in viral spread and invasion of target organs are shown. Neural spread
is not illustrated. GI, gastrointestinal; HIV, human immunodeficiency virus; HPV,
human papillomavirus.
(Modified from Nathanson N, Tyler KL. Entry, dissemination, shedding, and transmission
of viruses. In: Nathanson N, ed. Viral Pathogenesis. Philadelphia: Lippincott-Raven;
1997:13-33.)
Exposure of respiratory mucosa to virus by direct inoculation or inhalation is an
important route of viral entry into the host. A simple cough can generate up to 10,000
small, potentially infectious aerosol particles, and a sneeze can produce nearly 2
million. The distribution of these particles depends on a variety of environmental
factors, the most important of which are temperature, humidity, and air currents.
In addition to these factors, particle size is an important determinant of particle
distribution. In general, smaller particles remain airborne longer than larger ones.
Particle size also contributes to particle fate after inhalation. Larger particles
(>6 µm) are generally trapped in the nasal turbinates, whereas smaller particles may
ultimately travel to the alveolar spaces of the lower respiratory tract.
Fecal-oral transmission represents an additional important route of viral entry into
the host. Food, water, or hands contaminated by infected fecal material can facilitate
the entry of a virus via the mouth into the gastrointestinal tract, the environment
of which requires viruses that infect by this route to have certain physical properties.
Viruses capable of enteric transmission must be acid stable and resistant to bile
salts. Because conditions in the stomach and intestine are destructive to lipids contained
in viral envelopes, most viruses that spread by the fecal-oral route are nonenveloped.
Interestingly, many viruses that enter the host via the gastrointestinal tract require
proteolysis of certain capsid components to infect intestinal cells productively.
Treatment of mice with inhibitors of intestinal proteases blocks infection by reovirus
155
and rotavirus,
156
which demonstrates the critical importance of proteolysis in the initiation of enteric
infection by these viruses. The host microbiota is essential for infection by some
viruses.157, 158
To produce systemic disease, a virus must cross the mucosal barrier that separates
the luminal compartments of the respiratory, gastrointestinal, and genitourinary tracts
from the host's parenchymal tissues. Studies with reovirus illustrate one strategy
used by viruses to cross mucosal surfaces to invade the host after entry into the
gastrointestinal tract.159, 160 After oral inoculation of mice, reovirus adheres to
the surface of intestinal microfold cells (M cells) that overlie collections of intestinal
lymphoid tissue (Peyer's patches). In electron micrographs, reovirus virions can be
followed sequentially as they are transported within vesicles from the luminal to
the subluminal surface of M cells. Virions subsequently appear within Peyer's patches
and then spread to regional lymph nodes and extraintestinal lymphoid organs such as
the spleen. A similar pathway of spread has been described for poliovirus
161
and HIV,
162
suggesting that M cells represent an important portal for viral invasion of the host
after entry into the gastrointestinal tract.
Spread
Once a virus has entered the host, it can replicate locally or spread from the site
of entry to distant organs to produce systemic disease (see Fig. 134-6). Classic examples
of localized infections in which viral entry and replication occur at the same anatomic
site include respiratory infections caused by influenza virus, RSV, and rhinovirus;
enteric infections produced by norovirus and rotavirus; and dermatologic infections
caused by HPV (warts) and paravaccinia virus (milker's nodules). Other viruses spread
to distant sites in the host after primary replication at sites of entry. For example,
poliovirus spreads from the gastrointestinal tract to the central nervous system (CNS)
to produce meningitis, encephalitis, or poliomyelitis. Measles virus and varicella-zoster
virus (VZV) enter the host through the respiratory tract and then spread to lymph
nodes, skin, and viscera. Pathobiologic definitions of viruses based on spread potential
have begun to blur amid accumulating evidence that model agents of localized infection
may disseminate to distant sites. For example, rotavirus, an important cause of pediatric
acute gastroenteritis, replicates vigorously in villous tip epithelial cells of the
small intestine but is also frequently associated with viral antigen and RNA in blood,
the clinical significance of which is unclear.
163
Influenza virus is another case in point; viral RNA in blood is detected at a substantial
frequency in hematopoietic cell transplant recipients and correlates with more severe
disease and increased mortality.
164
Release of some viruses occurs preferentially from the apical or basolateral surface
of polarized cells, such as epithelial cells. In the case of enveloped viruses, polarized
release is frequently determined by preferential sorting of envelope glycoproteins
to sites of viral budding. Specific amino-acid sequences in these viral proteins direct
their transport to a particular aspect of the cell surface.165, 166 Polarized release
of virus at apical surfaces may facilitate local spread of infection, whereas release
at basolateral surfaces may facilitate systemic invasion by providing virus access
to subepithelial lymphoid, neural, or vascular tissues.
Many viruses use the bloodstream to spread in the host from sites of primary replication
to distant target tissues (see Fig. 134-6). In some cases, viruses may enter the bloodstream
directly, such as during a blood transfusion or via an arthropod bite. More commonly,
viruses enter the bloodstream after replication at some primary site. Important sites
of primary replication preceding hematogenous spread of viruses include Peyer's patches
and mesenteric lymph nodes for enteric viruses, bronchoalveolar cells for respiratory
viruses, and subcutaneous tissue and skeletal muscle for alphaviruses and flaviviruses.
In the case of reovirus, infection of endothelial cells leads to hematogenous dissemination
in the host.167, 168
Pioneering studies by Fenner with mousepox (ectromelia) virus suggest that an initial
low-titer viremia (primary viremia) serves to seed virus to a variety of intermediate
organs, where a period of further replication leads to a high-titer viremia (secondary
viremia) that disseminates virus to the ultimate target organs (Fig. 134-7
).
169
It is often difficult to identify primary and secondary viremias in naturally occurring
viral infections. However, replication of many viruses in reticuloendothelial organs
(e.g., liver, spleen, lymph nodes, bone marrow), muscle, fat, and even vascular endothelial
cells can play an important role in maintaining viremia.
168
FIGURE 134-7
Pathogenesis of mousepox virus infection.
Successive waves of viremia are shown to seed the spleen and liver and then the skin.
(From Fenner F. Mousepox [infectious ectromelia of mice]: a review. J Immunol. 1949;63:341-373.)
Viruses that reach the bloodstream may travel free in plasma (e.g., enteroviruses
and togaviruses) or in association with specific blood cells.
170
A number of viruses are spread hematogenously by macrophages (e.g., CMV, HIV, measles
virus) or lymphocytes (e.g., CMV, EBV, HIV, HTLV, measles virus). Although many viruses
have the capacity to agglutinate erythrocytes in vitro (a process called hemagglutination),
only in exceptional cases (e.g., Colorado tick fever virus) are erythrocytes used
to transport virus in the bloodstream.
The maintenance of viremia depends on the interplay among factors that promote virus
production and those that favor viral clearance. A number of variables that affect
the efficiency of virus removal from plasma have been identified. In general, the
larger the viral particle, the more efficiently it is cleared. Viruses that induce
high titers of neutralizing antibodies are more efficiently cleared than those that
do not induce humoral immune responses. Finally, phagocytosis of virus by cells in
the host reticuloendothelial system can contribute to viral clearance.
A major pathway used by viruses to spread from sites of primary replication to the
nervous system is through nerves. Numerous diverse viruses, including Borna disease
virus, coronavirus, HSV, poliovirus, rabies virus, reovirus, and Venezuelan equine
encephalitis virus (VEE), are capable of neural spread. Several of these viruses accumulate
at the neuromuscular junction after primary replication in skeletal muscle.171, 172
HSV appears to enter nerve cells via receptors that are located primarily at synaptic
endings rather than on the nerve cell body.
173
Spread to the CNS by HSV,
174
rabies virus,171, 172 and reovirus175, 176 can be interrupted by scission of the appropriate
nerves or by chemical agents that inhibit axonal transport. Neural spread of some
of these viruses occurs by the microtubule-based system of fast axonal transport.
177
Viruses are not limited to a single route of spread. VZV, for example, enters the
host by the respiratory route and then spreads from respiratory epithelium to the
reticuloendothelial system and skin via the bloodstream. Infection of the skin produces
the characteristic exanthem of chickenpox. The virus subsequently enters distal terminals
of sensory neurons and travels to dorsal root ganglia, where it establishes latent
infection. Reactivation of VZV from latency results in transport of the virus in sensory
nerves to skin, where it gives rise to vesicular lesions in a dermatomal distribution
characteristic of zoster or shingles.
Poliovirus is also capable of spreading by hematogenous and neural routes. Poliovirus
is generally thought to spread from the gastrointestinal tract to the CNS via the
bloodstream, although it has been suggested that the virus may spread via autonomic
nerves in the intestine to the brainstem and spinal cord.178, 179 This hypothesis
is supported by experiments using transgenic mice expressing the human poliovirus
receptor.
180
When these mice are inoculated with poliovirus intramuscularly in the hind limb, virus
does not reach the CNS if the sciatic nerve ipsilateral to the site of inoculation
is transected.
181
Once poliovirus reaches the CNS, axonal transport is the major route of viral dissemination.
Similar mechanisms of spread may be used by other enteroviruses.
Tropism
The capability of a virus to infect a distinct group of cells in the host is referred
to as tropism. For many viruses, tropism is determined by the availability of virus
receptors on the surface of a host cell. This concept was first appreciated in studies
of poliovirus when it was recognized that the capacity of the virus to infect specific
tissues paralleled its capacity to bind homogenates of the susceptible tissues in
vitro.
182
The importance of receptor expression as a determinant of poliovirus tropism was conclusively
demonstrated by showing that cells not susceptible for poliovirus replication could
be made susceptible by recombinant expression of the poliovirus receptor.
183
In addition to the availability of virus receptors, tropism can also be determined
by postattachment steps in viral replication, such as the regulation of viral gene
expression. For example, some viruses contain genetic elements, termed enhancers,
that act to stimulate transcription of viral genes.184, 185 Some enhancers are active
in virtually all types of cells, whereas others show exquisite tissue specificity.
The promoter-enhancer region of John Cunningham (JC) polyomavirus is active in cultured
human glial cells but not in HeLa cervical epithelial cells.
186
Cell-specific expression of the JC virus genome correlates well with the capacity
of this virus in immunocompromised persons to produce progressive multifocal leukoencephalopathy,
a disease in which JC virus infection is limited to oligodendroglia in the CNS.
Specific steps in virus–host interaction, such as the route of entry and pathway of
spread, also can strongly influence viral tropism. For example, encephalitis viruses
such as VEE are transmitted to humans by insect bites. These viruses undergo local
primary replication and then spread to the CNS by hematogenous and neural routes.
187
After oral inoculation, VEE is incapable of primary replication and spread to the
CNS, illustrating that tropism can be determined by the site of entry into the host.
Influenza virus buds exclusively from the apical surface of respiratory epithelial
cells,
188
which may limit its capacity to spread within the host and infect cells at distant
sites.
A wide variety of host factors can influence viral tropism. These include age, nutritional
status, and immune responsiveness, as well as certain genetic polymorphisms that affect
susceptibility to viral infection. Age-related susceptibility to infection is observed
for many viruses, including reovirus,189, 190 RSV,191, 192, 193 and rotavirus.194,
195 The increased susceptibility in young children to these viruses may in part be
due to immaturity of the immune response but also may be related to intrinsic age-specific
factors that enhance host susceptibility to infection. Nutritional status is a critical
determinant of the tropism and virulence of many viruses. For example, persons with
vitamin A deficiency have enhanced susceptibility to measles virus infection.196,
197 Similarly, the outcome of most viral infections is strongly linked to the immune
competence of the host.
The genetic basis of host susceptibility to viral infections is complex. Studies with
inbred strains of mice indicate that genetic variation can alter susceptibility to
viral disease by a variety of mechanisms.
198
These can involve differences in immune responses, variability in the ability to produce
antiviral mediators such as IFN, and differential expression of functional virus receptors.
Polymorphisms in the expression of chemokine receptor CCR5, which serves as a co-receptor
for HIV,55, 56, 57 are associated with alterations in susceptibility to HIV infection.199,
200
Persistent Infections
Many viruses are capable of establishing persistent infections, of which two types
are recognized: chronic and latent. Chronic viral infections are characterized by
continuous shedding of virus for prolonged periods of time. Congenital infections
with rubella virus and CMV and persistent infections with HBV and HCV are examples
of chronic viral infections. Latent viral infections are characterized by maintenance
of the viral genome in host cells in the absence of viral replication. Herpesviruses
and retroviruses can establish latent infections. The distinction between chronic
and latent infections is not readily apparent for some viruses, such as HIV, which
can establish both chronic and latent infections in the host.201, 202, 203 Viruses
capable of establishing persistent infections must have a means of evading the host
immune response and a mechanism of attenuating their virulence. Lentiviruses such
as equine infectious anemia virus
204
and HIV205, 206, 207 are capable of extensive antigenic variation resulting in escape
from neutralizing antibody responses by the host.
Several viruses encode proteins that directly attenuate the host immune response (e.g.,
the adenovirus E3/19K protein
208
and CMV US11 gene product
209
block cell surface expression of MHC class I proteins, resulting in diminished presentation
of viral antigens to cytotoxic T lymphocytes [CTLs]). The poxviruses encode a variety
of immunomodulatory molecules including CrmA, which blocks T-cell–mediated apoptosis
of virus-infected cells.
210
In some cases (e.g., the CNS), preferential sites for persistent viral infections
are not readily accessible by the immune system,
211
which may favor establishment of persistence.
Viruses and Cancer
Several viruses produce disease by promoting malignant transformation of host cells.
Work by Peyton Rous with an avian retrovirus was the first to demonstrate that viral
infections can cause cancer.
212
Rous sarcoma virus encodes an oncogene, v-src, which is a homologue of a cellular
proto-oncogene, c-src.
213, 214 Cells infected with Rous sarcoma virus become transformed.215, 216, 217,
218, 219 Several viruses are associated with malignancies in humans. EBV is associated
with many neoplasms, including Burkitt's lymphoma, Hodgkin's disease, large B-cell
lymphoma, leiomyosarcoma, and nasopharyngeal carcinoma. HBV and HCV are associated
with hepatocellular carcinoma. HPV is associated with cervical cancer and a variety
of anogenital and esophageal neoplasms. Kaposi sarcoma–associated herpesvirus is associated
with Kaposi sarcoma and primary effusion lymphoma in persons with HIV infection.
Often, the linkage of a virus to a particular neoplasm can be attributed to transforming
properties of the virus itself. For example, EBV encodes several latency-associated
proteins that are responsible for immortalization of B cells; these proteins likely
play crucial roles in the pathogenesis of EBV-associated malignancies.
220
Similarly, HPV encodes the E6 and E7 proteins that block apoptosis112, 113, 114 and
induce cell cycle progression,110, 111 respectively. It is hypothesized that unregulated
expression of these proteins induced by the aberrant integration of the HPV genome
into host DNA is responsible for malignant transformation.
221
The tumorigenicity of polyomaviruses, which are oncogenic in rodent species, is mediated
by a family of viral proteins known as tumor (T) antigens. Reminiscent of the HPV
E6 and E7 proteins, T antigens induce cell cycling and block the ensuing cellular
apoptotic response to unscheduled cell division.
222
The normally episomal polyomavirus genome becomes integrated into cellular DNA during
neoplastic transformation of nonpermissive cells unable to support the entire viral
replication program, which would otherwise culminate in cell death. Discovery of a
human polyomavirus clonally integrated into cells of an aggressive form of skin cancer,
Merkel cell carcinoma,
2
substantiates the long-standing suspicion that polyomaviruses can also promote neoplasia
in humans.
In other cases, mechanisms of malignancy triggered by viral infection are less clear.
HCV is an RNA-containing virus that lacks reverse transcriptase and a means of viral
genome integration. However, chronic infection with HCV is strongly associated with
hepatocellular cancer.
223
It is possible that increased cell turnover and inflammatory mediators elicited by
chronic HCV infection increase the risk of genetic damage, which results in malignant
transformation. Some HCV proteins may also play a contributory role in neoplasia.
For example, the HCV core protein can protect cells against apoptosis induced by a
variety of stimuli, including tumor necrosis factor-α (TNF-α).
224
Viral Virulence Determinants
Viral surface proteins involved in attachment and entry influence the virulence of
diverse groups of viruses. For example, polymorphisms in the attachment proteins of
influenza virus,225, 226 polyomavirus,
227
reovirus,
228
rotavirus,
229
and VEE
230
are strongly linked to virulence and can be accurately termed virulence determinants.
Viral attachment proteins can serve this function by altering the affinity of virus–receptor
interactions or modulating the kinetics of viral disassembly. Importantly, sequences
in viral genomes that do not encode protein can also influence viral virulence. Mutations
that contribute to the attenuated virulence of the Sabin strains of poliovirus are
located in the 5′ nontranslated region of the viral genome.
231
These mutations attenuate poliovirus virulence by altering the efficiency of viral
protein synthesis.
A number of viruses encode proteins that enhance virulence by modulation of host immune
responses. Illustrative examples include the influenza A NS1 protein, which interferes
with activation of cellular innate immune responses to viral infection,
232
and translation products of the adenovirus E3 transcriptional unit, which serve to
prevent cytotoxic T-cell recognition of virally infected cells and block immunologically
activated signaling pathways that lead to infected-cell death.208, 233 In many cases,
these proteins are dispensable for viral replication in cultured cells. In this way,
immunomodulatory viral virulence determinants resemble classic bacterial virulence
factors such as various types of secreted toxins.
Host Responses to Infection
The immune response to viral infection involves complex interactions among leukocytes,
nonhematopoietic cells, signaling proteins, soluble proinflammatory mediators, antigen-presenting
molecules, and antibodies. These cells and molecules collaborate in a highly regulated
fashion to limit viral replication and dissemination through recognition of broadly
conserved molecular signatures, followed by virus-specific adaptive responses that
further control infection and establish antigen-selective immunologic memory. The
innate antiviral response is a local, transient, antigen-independent perimeter defense
strategically focused at the site of virus incursion into an organ or tissue. Mediated
by ancient families of membrane-associated and cytosolic molecules known as pattern
recognition receptors (PRRs), the innate immune system detects pathogen-associated
molecular patterns (PAMPs), which are fundamental structural components of microbial
products including nucleic acids, carbohydrates, and lipids.
234
Viral PAMPs in the form of single-stranded (ss)RNA, dsRNA, and DNA evoke the innate
immune response through two groups of PRRs: the transmembrane Toll-like receptors
(TLRs) and the cytosolic nucleic acid sensors. The latter include retinoic acid inducible
gene-I (RIG-I)-like receptors, nucleotide-binding domain and leucine-rich-repeat containing
proteins (NLRs) such as NLRP, and DNA sensors.
235
Nucleic acid binding by PRRs activates signaling pathways leading to the production
and extracellular release of IFN-α, IFN-β, and proinflammatory cytokines such as interleukin
(IL)-1β and IL-18. IFN-α and IFN-β engage the cell surface IFN-α/β receptor and thereby
mediate expression of hundreds of gene products that corporately suppress viral replication
and establish an intracellular antiviral state in neighboring uninfected cells. Well-described
IFN-inducible gene products include the latent enzymes dsRNA-dependent protein kinase
(PKR) and 2′,5′-oligoadenylate synthetase (OAS), both of which are activated by dsRNA.
236
PKR inhibits the initiation of protein synthesis through phosphorylation of translation
initiation factor eIF2α. The 2′,5′-oligoandenylates generated by OAS bind and activate
endoribonuclease RNAse L, which degrades viral mRNA. In addition to mediating an intracellular
antiviral state, IFN-α/β also stimulates the antigen-independent destruction of virus-infected
cells by a specialized population of lymphocytes known as natural killer (NK) cells.
237
Importantly, IFNs bridge innate and adaptive antiviral immune responses through multiple
modes of action, which include enhancing viral antigen presentation by class I MHC
proteins,
238
promoting the proliferation of MHC class I–restricted CD8+ CTLs,
239
and facilitating the functional maturation of dendritic cells.
240
Proinflammatory mediators IL-1β and IL-18 pleiotropically stimulate and amplify the
innate immune response through induction of other inflammatory mediators, immune cell
activation, and migration of inflammatory cells into sites of infection.
241
These molecules perform essential functions in host antiviral defense.
242
The adaptive immune response confers systemic and enduring pathogen-selective immunity
through expansion and functional differentiation of viral antigen-specific T and B
lymphocytes. Having both regulatory and effector roles, T lymphocytes are centrally
positioned in the scheme of adaptive immunity. The primary cell type involved in the
resolution of acute viral infection is the CD8+ CTL, which induces lethal proapoptotic
signaling in virus-infected cells upon recognition of endogenously produced viral
protein fragments presented by cell surface MHC class I molecules. Less frequently,
CD4+ T cells, which recognize MHC class II–associated viral oligopeptides processed
from exogenously acquired proteins, also demonstrate cytotoxicity against viral antigen-presenting
cells.
243
The usual function of CD4+ T lymphocytes is to orchestrate and balance cell-mediated
(CTL) and humoral (B lymphocyte) responses to infection. Classes of CD4+ helper T-cell
subsets—Th1, Th2, Th17, Treg (regulatory T), and Tfh (follicular helper T)—have been
defined based on characteristic patterns of cytokine secretion and effector activities.244,
245 Th1 and Th2 lymphocytes are usually associated with the development of cell-mediated
and humoral responses, respectively, to viral infection. Th17 and Treg CD4+ subsets
are important for control of immune responses and prevention of autoimmunity, but
their precise roles in viral disease and antiviral immunity are not clear. For certain
persistent viral infections, such as those caused by HIV and HSV, Treg cells might
exacerbate disease through suppression of CTLs or, paradoxically, ameliorate illness
by attenuating immune-mediated cell and tissue injury.
246
Tfh cells promote differentiation of antigen-specific memory B lymphocytes and plasma
cells within germinal centers.
247
Therefore, Tfh cells likely occupy a central place in the humoral response to viral
infection and vaccination. Although Tfh cell functions are not unique to antiviral
responses, chronic viral infections including HBV and HIV appear to stimulate proliferation
of these cells.248, 249 The Tfh phenotype may interconvert with other T-helper lineage
profiles and thus represent a differentiation intermediate rather than a unique CD4+
T lymphocyte subset.
245
The primacy of cell-mediated immune responses in combating viral infections is revealed
by the extreme vulnerability of individuals to chronic and life-threatening viral
diseases when cellular immunity is dysfunctional. Those with acquired immunodeficiency
syndrome (AIDS) exemplify the catastrophic consequences of collapsing cell-mediated
immunity; progressive multifocal leukoencephalopathy caused by JC polyomavirus, along
with severe mucocutaneous and disseminated CMV, HSV, and VZV infections, are frequent
complications of vanishing CD4+ T cells. Similarly, iatrogenic cellular immunodeficiency
associated with hematopoietic stem cell and solid-organ transplantation or antineoplastic
treatment regimens predisposes to severe, potentially fatal infections with herpesviruses
and respiratory viral pathogens such as adenovirus, PIV, and RSV,
250
all of which normally produce self-limited illness in immunocompetent hosts. Prevention
and management of serious viral respiratory infections are significant challenges
in myelosuppression units because of the communicability of respiratory viruses and
paucity of effective drugs to combat these ubiquitous agents. Individuals with significantly
impaired cell-mediated immunity are also at increased risk for enhanced viral replication
and systemic disease following immunization with live, attenuated viral vaccines (e.g.,
measles-mumps-rubella [MMR] and VZV vaccines). Hence, live viral vaccines are generally
contraindicated for immunocompromised persons (see Chapter 321). TNF-α inhibitor therapy,
increasingly employed to manage a variety of rheumatologic and inflammatory diseases,
enhances the risk of HBV reactivation with potentially life-threatening consequences.
251
Preventive and interventional HBV treatment strategies are necessary to circumvent
complications of uncontrolled viral replication in these patients.
In contrast to cell-mediated immune mechanisms, humoral responses are usually not
a determinative factor in the resolution of primary viral infections. (One notable
exception is a syndrome of chronic enteroviral meningitis in the setting of agammaglobulinemia.
252
) However, for most human viral pathogens, the presence of antibody is associated
with protection against initial infection in vaccinees or reinfection in hosts with
a history of natural infection.
253
Longitudinal studies indicate that levels of protective serum antibodies (induced
by natural infection or immunization) to common viruses, including EBV, measles, mumps,
and rubella, are remarkably stable, with calculated antibody half-lives ranging from
several decades to thousands of years.
254
The protective role of antibodies on secondary exposure is frequently explained as
interruption of viremic spread where a hematogenous phase is involved, such as occurs
with measles, mumps, and rubella viruses, poliovirus, VZV, and most arboviruses. Nevertheless,
most human viruses, excluding insect-transmitted agents, enter their hosts by transgression
of a mucosal barrier, frequently undergoing primary replication in mucosal epithelium
or adjacent lymphoid tissues. Neutralizing IgA exuded onto mucosal epithelial surfaces
may protect against primary infection at this portal of viral entry. A classic example
is gut mucosal immunity induced by orally administered Sabin poliovirus vaccine containing
live-attenuated virus. Secretory IgA against poliovirus blocks infection at the site
of primary replication and consequently interrupts the chain of viral transmission,
although fully virulent revertant viruses arise at regular frequency in vaccine recipients,
who may develop disease and also transmit revertant strains to nonimmune individuals.
255
Clinical and experimental studies of immunity to HIV have led to the recognition that
resident immune responses at exposed mucosal surfaces are likely critical components
of host resistance to primary HIV infection, and achievement of potent mucosal immunity
has emerged as an important consideration for the design of candidate HIV vaccines.
256
Despite the appearance of serum neutralizing antibodies to HIV several weeks after
infection, viral eradication is thwarted by selection of neutralization-resistant
variant strains from a mutant pool, which is perpetually replenished because of extreme
plasticity within neutralization determinants on the viral envelope glycoproteins.
257
Identification of epitopes bound by broadly neutralizing antiviral antibodies has
provided potential new targets for structure-based vaccine design.
258
Protection against viral infection by serum immunoglobulins is often correlated with
antibody-mediated neutralization of viral infectivity in cultured cells. Antibodies
interrupt the viral life cycle at early steps, which may include cross-linking virion
particles into noninfectious aggregates, steric hindrance of receptor engagement,
and interference with viral disassembly.
259
It is presumed that virus neutralization in cell culture by human serum is reflective
of antibody activity in the intact host, but the mechanistic basis of infection blockade
and disease prevention by antibodies in vivo is difficult to define precisely. For
example, exclusively in vivo functions of the humoral antiviral response include Fc-mediated
virion phagocytosis260, 261 and antibody-dependent cell-mediated cytotoxicity (ADCC).
ADCC responses require effectors from both the innate and adaptive systems, NK cells
and antibodies, respectively.
262
The basis of ADCC is FcγRIIIa receptor-dependent recognition by NK cells of virus-specific
IgG bound to antigens expressed on the surface of infected cells, leading to release
of perforin and granzymes from NK cells that eventuate in target cell apoptosis. Neutrophils,
lymphocytes, and macrophages also possess Fc receptors and may participate in ADCC.